ArticleGerms2017
Molecular characterization of antimicrobial resistance in clinical
Article in Germs, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 25 citations in OpenAlex.
- Emergence of a novel genotype of extensively drug-resistantAntimicrobial stewardship & healthcare epidemiology : ASHE · 2026Article
- Shigella sonnei: epidemiology, evolution, pathogenesis, resistance and host interactions.Nature reviews. Microbiology · 2025Review
- Investigation of the vaccine potential of anVaccine: X · 2024Article
- Review
- Article
- Structural chemistry and molecular-level interactome reveals histidine kinase EvgS to subvert both antimicrobial resistance and virulence in3 Biotech · 2022Article
- Proteome based mapping and molecular docking revealed DnaA as a potential drug target againstSaudi journal of biological sciences · 2022Article
- Shigella sonnei: virulence and antibiotic resistance.Archives of microbiology · 2021Review
- Article
- Shigella flexneri: an emerging pathogen.Folia microbiologica · 2020Review
- Differential gene expression profile ofFuture science OA · 2020Article
- Antimicrobial susceptibility profile & resistance mechanisms of Global Antimicrobial Resistance Surveillance System (GLASS) priority pathogens from India.The Indian journal of medical research · 2019Review
- Antimicrobial resistance, virulence & plasmid profiles among clinical isolates ofThe Indian journal of medical research · 2019Article
- Need to improve availability of "access" group antibiotics and reduce the use of "watch" group antibiotics in India for optimum use of antibiotics to contain antimicrobial resistance.Journal of pharmaceutical policy and practice · 2019Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
background
methodsFrom 2014 to 2015, 338
resultsThe resistance profile of the study isolates varied by species and year.
conclusion
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.